Nachrichten zur Moderna Inc. Aktie

Stocks making the biggest moves premarket: Moderna, Lumentum, Intel, monday.com & more

These are the stocks posting the largest moves premarket.…

Moderna shares extend gains as hantavirus vaccine work draws attention

Moderna Inc (NASDAQ:MRNA, XETRA:0QF) shares continued to extend recent gains on Monday as investors welcomed reports that the company is…

These Stocks Are Today’s Movers: Moderna, Micron, Intel, Apollo Global, and More

Moderna jumps after the U.S. health department says a passenger on a repatriation flight tested mildly positive for hantavirus. Moderna…

Moderna shares jump 8% after U.S. national tests positive for hantavirus

Moderna shares jump 8% after U.S. national tests positive for hantavirus…

Moderna im Hantavirus-Fieber! Zwischen spekulativem Kurssprung und harten Quartalsrealitäten!

Ein lokaler Ausbruch des Hantavirus auf einem Kreuzfahrtschiff treibt die Moderna-Aktie (MRNA) an. Doch abseits der medialen Aufmerksamkeit offenbaren die…

Moderna stock surges on hantavirus vaccine development plans

Moderna stock surges on hantavirus vaccine development plans…

Moderna stock surges on hantavirus vaccine research confirmation

Moderna stock surges on hantavirus vaccine research confirmation…

Moderna: Hantavirus-Schlagzeilen treiben Impfstoff-Aktie an

Das Hantavirus ist auf einem kleinen Kreuzfahrtschiff im Atlantik ausgebrochen. Die Weltgesundheitsorganisation (WHO) hat inzwischen fünf von acht Verdachtsfällen als…

Novavax (NVAX) Q3 2025 Earnings Transcript

Image source: The Motley Fool.DateThursday, Nov. 6, 2025, at 8:30 a.m. ETCall participantsPresident and Chief Executive Officer — John JacobsHead…

Moderna, Inc. (MRNA) Q1 2026 Earnings Call Transcript

…

Moderna Reports Q1 Loss, Stock Jumps on Strong International Sales

MRNA narrows Q1 loss and beats revenue estimates as international vaccine sales surge, lifting shares despite hefty litigation charges.…

Moderna CEO on Earnings, Flu Shots and Skin Cancer Trials

Moderna’s first-quarter sales beat expectations, as the struggling vaccine maker that’s faced resistance from the Trump administration has found new…

Moderna reports mixed Q1 results as revenue beats estimates but litigation charge weighs on earnings

Moderna Inc (NASDAQ:MRNA, XETRA:0QF) reported first quarter 2026 revenue that came in well above Wall Street expectations, but posted a…

Moderna beats revenue expectations despite wider loss

Moderna beats revenue expectations despite wider loss…

Moderna tops quarterly revenue estimates on stronger international COVID vaccine sales

Moderna surpassed Wall Street estimates for first-quarter revenue on Friday, ?helped by better-than-expected sales of its COVID-19 vaccine in international…

CureVac sues Moderna for patent infringement over COVID-19 vaccines

CureVac sues Moderna for patent infringement over COVID-19 vaccines…

CureVac sues Moderna over mRNA vaccine patents

CureVac sues Moderna over mRNA vaccine patents…

Moderna (MRNA) May Report Negative Earnings: Know the Trend Ahead of Next Weeks Release

Moderna (MRNA) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…

Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing

In the most recent trading session, Moderna (MRNA) closed at $55.6, indicating a +2.53% shift from the previous trading day.…

Moderna starts late-stage trial of bird flu vaccine in US, UK

Moderna starts late-stage trial of bird flu vaccine in US, UK…

Moderna (MRNA) Outpaces Stock Market Gains: What You Should Know

Moderna (MRNA) closed the most recent trading day at $54.26, moving +2.69% from the previous trading session.…

Moderna (MRNA) Stock Declines While Market Improves: Some Information for Investors

In the latest trading session, Moderna (MRNA) closed at $51.3, marking a -1.54% move from the previous day.…

Moderna eyes international markets as growth driver, says Bank of America

Moderna Inc (NASDAQ:MRNA, XETRA:0QF) is expected to highlight progress in international COVID-19 vaccine markets when it reports first quarter 2026…

Bank of America flags international opportunities as key growth driver for Moderna

Moderna Inc (NASDAQ:MRNA, XETRA:0QF) is expected to highlight progress in international COVID-19 vaccine markets when it reports first quarter 2026…

Moderna Aktienanalyse: Zwischen Gegenwind und Comeback-Fantasie - Warum RBC Capital vorsichtig optimistisch bleibt

Bad Marienberg (www.aktiencheck.de)???? Moderna im Realitätscheck: Vom Pandemie-Gewinner zur strategischen WetteDie Aktie von Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9, Ticker-Symbol:…

Moderna: Speculative Buy For Aggressive Investors Betting On mRNAs Future

Modernas mRNA pipeline—cancer vaccines, Norovirus, and a European comeback—could fuel triple-digit EPS growth by 2030. Read why MRNA stock is…

Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know

A number of stocks fell in the afternoon session after reports revealed that the US may impose up to 100%…

Moderna (MRNA) Stock Dips While Market Gains: Key Facts

In the closing of the recent trading day, Moderna (MRNA) stood at $49.2, denoting a -1.66% move from the preceding…

Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.…

Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after reports revealed that the US may impose up…

Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know

Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know…

Moderna (MRNA) Falls More Steeply Than Broader Market: What Investors Need to Know

Moderna (MRNA) concluded the recent trading session at $49.56, signifying a -7.49% move from its prior days close.…

These Top Stocks Have a Big China Problem to Solve

Modern problems require modern solutions, and thats what Detroit automakers are currently figuring out in China.…

ImmunityBio vs. Moderna: Which Biotech Has More Upside Potential?

IBRX and MRNA hinge on single-drug success, but pipeline depth, growth plans and risks set them apart in the race…

Moderna Stock is Soaring. Is It Too Late to Buy?

Modernas full pipeline may fuel long-term growth.…

Moderna (MRNA) Suffers a Larger Drop Than the General Market: Key Insights

In the latest trading session, Moderna (MRNA) closed at $51.38, marking a -1.89% move from the previous day.…

Pfizer vs Moderna: Which Pharma Stock Has More Upside?

They arent just "pandemic stocks."…

OTC Markets Hosts Virtual Investor Presentation with Dr. Seth Lederman, Co-Founder, CEO, and Chairman of Tonix Pharmaceuticals, and David Bautz, PhD, Senior Analyst at Zacks SCR

NASDAQ: TNXPJohn Viglotti: Hello, and welcome to the Life Sciences Investor Forum. On behalf of OTC Markets and our co-host,…

Moderna (MRNA) Declines More Than Market: Some Information for Investors

In the most recent trading session, Moderna (MRNA) closed at $52.56, indicating a -1.55% shift from the previous trading day.…

Stocks making the biggest moves midday: Coinbase, CoreWeave, KKR, Moderna, Brown-Forman & more

Here are some of the stocks making the biggest moves in midday trading.…

Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang

Moderna shares rose 10% in premarket trading on Wednesday after the company settled a long-running legal battle over the technology…

Stocks making the biggest moves premarket: Moderna, Ross Stores, Box, Gitlab and more

These are the stocks posting the largest moves in premarket trading.…

Moderna to pay up to $2.25B to settle COVID vaccine patent matter

Moderna Inc (NASDAQ:MRNA, XETRA:0QF) stock added almost 9% after it was announced that the drugmaker has agreed to pay up…

Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna

BASEL, Switzerland and VANCOUVER, British Columbia, March 03, 2026 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid…

Roivant Announces Genevant Sciences’ and Arbutus Biopharma’s $2.25 Billion Global Settlement With Moderna

BASEL, Switzerland and LONDON and NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced…

Grünes Licht für erste Kombi-Impfung gegen Covid und Grippe

AMSTERDAM (dpa-AFX) - Die EU-Arzneimittelbehörde EMA hat grünes Licht gegeben für den ersten Kombi-Impfstoff gegen Corona…

Pivotal-Point Nachverfolgung Moderna (MRNA): Abkehr vom COVID-Fokus nach Durchbruch bei personalisierter Krebs-Immuntherapie!

Moderna ist ein Pionier im Bereich der mRNA-Technologie und wurde durch den Erfolg seines COVID-19-Vakzins weltweit bekannt. Am 18. Februar…

dpa-AFX ProFeed